A triple bottom in A2 Milk (ASX:A2M): Time for a rebound?

Marc Kennis Marc Kennis, February 2, 2022

A2 Milk has fallen from grace, but better times are ahead

A2 Milk (ASX:A2M) is one of those former market darlings, like Appen (ASX:APX), that have fallen from grace in the last few years. With the disappearance of the Daigous, AM2’s lucrative distribution channel into China largely evaporated. Daigous are Chinese expatriates purchasing products from overseas and shipping them back to consumers in China. We recently spoke about A2M on AusBiz.

However, with new management in place and a fresh China strategy, we believe better times are ahead for A2M and its shareholders, especially given the current valuation.

 

GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER

 
The stocks is cheap on consensus EBITDA growth estimates

The shares are currently trading at EV/EBITDA multiples of 13.6x and 10.6x for FY23 and FY24 respectively. FY23 starts in 5 months. But looking at consensus estimates for those years, we can see the market is expecting EBITDA growth of 32.5% and 28%.

In other words, on our beloved EV/EBITDA-to-EBITDA-growth metric, A2M is trading at 0.42 and 0.38 for these years, pretty attractive!

 

The chart is showing multiple bottoms

When looking at the first A2M price chart below, we can see that, following the stock’s strong decline since mid-2020, it has found very solid support around the $5 level.

 

A2M

A2M five-year chart (Source: Tradingview)

 

In fact, zooming in on the last 10 months of trading we can see the stock has formed three bottoms in the $5.06-$5.30 range. We believe that is a very strong sign of a change in market sentiment for A2 Milk.

 

A2M last 10 months

Shorter term A2M price chart (Source: Tradingview)

 

 
How to play A2M?

Combined with the company’s strategic shift when it comes to targeting the important Chinese market, we believe the current share price levels offer solid investment opportunities. Firstly, for trading-oriented investors, we believe a trade up to around $7 should be feasible. Investors focused on the longer term could buy A2M to play the new China strategy that should play out in the next three years.

Whatever your investment strategy might be, we believe A2 Milk currently offers something for everyone, except for shorters.

 

Check out our recent chat with AusBiz on A2 Milk.

A2 Milk (ASX:A2M): New Formula For Success

Disclosure: Pitt Street Research/Stocks Down Under directors own shares in A2M.

 

Need more stock ideas?

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Imugene

Imugene (ASX:IMU): This exciting biotech has multiple clinical trial readouts expected in the next 12 months

Imugene (ASX:IMU) is still valued at over $400m, in spite of being valued at over $2bn back in 2021 and…

ASX stocks with obscure HQ locations

Here are 5 ASX stocks with obscure HQ locations

Here are 5 ASX stocks with obscure HQ locations   Maas Group (ASX:MGH) – Dubbo, NSW This company is based…

Mastercard or Visa

Mastercard or Visa? Which of these 2 stocks appears more attractive?

Should you invest in Mastercard or Visa? It is a difficult question for investors to answer. These payment giants hold…